+ |
CyclinE/CDK2 | up-regulates activity
phosphorylation
|
TICRR |
0.34 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-273600 |
Ser1001 |
DIGVVEEsPEKGDEI |
in vitro |
|
pmid |
sentence |
21646402 |
We found that Treslin also associated with TopBP1 in a Cdk-regulated manner in human cells and that Treslin was phosphorylated within a conserved Cdk consensus target sequence (on S976 in X. laevis and S1000 in humans). Recombinant human Cdk2-cyclin E also phosphorylated this residue of Treslin in vitro very effectively. |
|
Publications: |
1 |
Organism: |
In Vitro |
+ |
CyclinE/CDK2 | down-regulates quantity by destabilization
phosphorylation
|
SNAI2 |
0.292 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276629 |
Ser104 |
KDHSGSEsPISDEEE |
Homo sapiens |
|
pmid |
sentence |
24662826 |
At G1/S transition, cyclin E-cyclin-dependent kinase 2 mediates the phosphorylation of Slug at Ser-54 and Ser-104, resulting in its ubiquitylation and degradation. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276628 |
Ser54 |
ILSSGAYsPITVWTT |
Homo sapiens |
|
pmid |
sentence |
24662826 |
At G1/S transition, cyclin E-cyclin-dependent kinase 2 mediates the phosphorylation of Slug at Ser-54 and Ser-104, resulting in its ubiquitylation and degradation. |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
+ |
CyclinE/CDK2 | up-regulates activity
phosphorylation
|
UNG |
0.267 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276098 |
Ser12 |
KTLYSFFsPSPARKR |
Homo sapiens |
HeLa Cell |
pmid |
sentence |
18079698 |
We investigated the ability of four active CDK/cyclin pairs to phosphorylate UNG2 in vitro.When UNG2 was subjected to in vitro phosphorylation by either of these sets of CDK/cyclins, multiple phosphorylated forms of UNG2 were observed (Figure 5B). Mass spectrometry analyses revealed that the ‘early' CDK4/cyclin D and CDK2/cyclin E kinases were able to phosphorylate all three UNG2 Ser/Thr residues observed in vivo (only CDK2/cyclin E shown). Of these, only S64 was phosphorylated by the ‘late' CDK2/cyclin A and CDK1/cyclin B kinases.Mass spectrometry analyses revealed that the ‘early' CDK4/cyclin D and CDK2/cyclin E kinases were able to phosphorylate all three UNG2 Ser/Thr residues observed in vivo (only CDK2/cyclin E shown). Of these, only S64 was phosphorylated by the ‘late' CDK2/cyclin A and CDK1/cyclin B kinases (Figure 5B, upper panels) in agreement with the accumulation of this phosphorylation in G2 (Figure 3B). In addition, (unspecific) phosphorylation by all kinases was observed at S12 and S14. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276100 |
Ser14 |
LYSFFSPsPARKRHA |
Homo sapiens |
HeLa Cell |
pmid |
sentence |
18079698 |
We investigated the ability of four active CDK/cyclin pairs to phosphorylate UNG2 in vitro.When UNG2 was subjected to in vitro phosphorylation by either of these sets of CDK/cyclins, multiple phosphorylated forms of UNG2 were observed (Figure 5B). Mass spectrometry analyses revealed that the ‘early' CDK4/cyclin D and CDK2/cyclin E kinases were able to phosphorylate all three UNG2 Ser/Thr residues observed in vivo (only CDK2/cyclin E shown). Of these, only S64 was phosphorylated by the ‘late' CDK2/cyclin A and CDK1/cyclin B kinases.Mass spectrometry analyses revealed that the ‘early' CDK4/cyclin D and CDK2/cyclin E kinases were able to phosphorylate all three UNG2 Ser/Thr residues observed in vivo (only CDK2/cyclin E shown). Of these, only S64 was phosphorylated by the ‘late' CDK2/cyclin A and CDK1/cyclin B kinases (Figure 5B, upper panels) in agreement with the accumulation of this phosphorylation in G2 (Figure 3B). In addition, (unspecific) phosphorylation by all kinases was observed at S12 and S14. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276097 |
Ser23 |
ARKRHAPsPEPAVQG |
Homo sapiens |
HeLa Cell |
pmid |
sentence |
18079698 |
We investigated the ability of four active CDK/cyclin pairs to phosphorylate UNG2 in vitro.When UNG2 was subjected to in vitro phosphorylation by either of these sets of CDK/cyclins, multiple phosphorylated forms of UNG2 were observed (Figure 5B). Mass spectrometry analyses revealed that the ‘early' CDK4/cyclin D and CDK2/cyclin E kinases were able to phosphorylate all three UNG2 Ser/Thr residues observed in vivo (only CDK2/cyclin E shown). Of these, only S64 was phosphorylated by the ‘late' CDK2/cyclin A and CDK1/cyclin B kinases.Mass spectrometry analyses revealed that the ‘early' CDK4/cyclin D and CDK2/cyclin E kinases were able to phosphorylate all three UNG2 Ser/Thr residues observed in vivo (only CDK2/cyclin E shown). Of these, only S64 was phosphorylated by the ‘late' CDK2/cyclin A and CDK1/cyclin B kinases (Figure 5B, upper panels) in agreement with the accumulation of this phosphorylation in G2 (Figure 3B). In addition, (unspecific) phosphorylation by all kinases was observed at S12 and S14. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276099 |
Thr60 |
AGQEEPGtPPSSPLS |
Homo sapiens |
HeLa Cell |
pmid |
sentence |
18079698 |
We investigated the ability of four active CDK/cyclin pairs to phosphorylate UNG2 in vitro.When UNG2 was subjected to in vitro phosphorylation by either of these sets of CDK/cyclins, multiple phosphorylated forms of UNG2 were observed (Figure 5B). Mass spectrometry analyses revealed that the ‘early' CDK4/cyclin D and CDK2/cyclin E kinases were able to phosphorylate all three UNG2 Ser/Thr residues observed in vivo (only CDK2/cyclin E shown). Of these, only S64 was phosphorylated by the ‘late' CDK2/cyclin A and CDK1/cyclin B kinases.Mass spectrometry analyses revealed that the ‘early' CDK4/cyclin D and CDK2/cyclin E kinases were able to phosphorylate all three UNG2 Ser/Thr residues observed in vivo (only CDK2/cyclin E shown). Of these, only S64 was phosphorylated by the ‘late' CDK2/cyclin A and CDK1/cyclin B kinases (Figure 5B, upper panels) in agreement with the accumulation of this phosphorylation in G2 (Figure 3B). In addition, (unspecific) phosphorylation by all kinases was observed at S12 and S14. |
|
Publications: |
4 |
Organism: |
Homo Sapiens |
+ |
CyclinE/CDK2 | up-regulates quantity by stabilization
phosphorylation
|
POU5F1 |
0.325 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-264438 |
Ser12 |
LASDFAFsPPPGGGG |
in vitro |
|
pmid |
sentence |
31306665 |
Recently, Liu et al. [3] identified CyclinE/CDK2 to be the kinase phosphorylating OCT4 on serine 12 (S12), serine 355 (S355) and threonine 322 (T322) by elegantly combining genetics and biochemistry. Knockout of all five G1 cyclins (D1, D2, D3, E1 and E2) in mESCs (coined Q-KO cells) and consequent inactivation of CDK2/4/ 6 leads to perturbation of the pluripotent state and to the adaption of the trophectoderm cell fate. This was attributed to reduced phosphorylation of OCT4 (as well as SOX2 and NANOG) leading to an increase of protein turnover [3]. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-264436 |
Ser12 |
LASDFAFsPPPGGGG |
in vitro |
|
pmid |
sentence |
31306665 |
Recent work found that CyclinE/CDK2 can phosphorylate OCT4 on serine 12 (S12), serine 355 (S355) and threonine 322 (T322) in vitro|Phosphorylation of OCT4 on S12 has been previously implicated to stabilize OCT4 by binding to PIN1, thereby preventing ubiquitinylation by WWP2. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-264437 |
Ser12 |
LASDFAFsPPPGGGG |
in vitro |
|
pmid |
sentence |
31306665 |
Recently, Liu et al. [3] identified CyclinE/CDK2 to be the kinase phosphorylating OCT4 on serine 12 (S12), serine 355 (S355) and threonine 322 (T322) by elegantly combining genetics and biochemistry. Knockout of all five G1 cyclins (D1, D2, D3, E1 and E2) in mESCs (coined Q-KO cells) and consequent inactivation of CDK2/4/ 6 leads to perturbation of the pluripotent state and to the adaption of the trophectoderm cell fate. This was attributed to reduced phosphorylation of OCT4 (as well as SOX2 and NANOG) leading to an increase of protein turnover [3]. |
|
Publications: |
3 |
Organism: |
In Vitro |
+ |
CyclinE/CDK2 | up-regulates
phosphorylation
|
COIL |
0.389 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216733 |
Ser184 |
NEEAKRKsPKKKEKC |
Homo sapiens |
HeLa Cell, Neuron |
pmid |
sentence |
11102515 |
In particular, we have recently found that the cdk2/cyclin e complex can phosphorylate coilin in vitro . there is but a single consensus cdk2/cyclin e phosphorylation site in coilin, located at serine 184. when serine 184 was mutated to an alanine (s184a), mimicking a dephosphorylated state, a nucleolar mislocalization similar to that of gfp-coilin(1__ _248) was observed |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CyclinE/CDK2 | down-regulates
phosphorylation
|
MYOD1 |
0.538 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216706 |
Ser200 |
YSGDSDAsSPRSNCS |
Homo sapiens |
|
pmid |
sentence |
21902831 |
Cyclin e/cdk2 can phosphorylate myod at serine 200, which causes ubiquitination and degradation of this transcription factor during g1, preventing its accumulation and a commitment to differentiation. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | IGF and Myogenesis |
+ |
CyclinE/CDK2 | up-regulates
phosphorylation
|
CDC25C |
0.598 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216721 |
Ser214 |
SRSGLYRsPSMPENL |
Homo sapiens |
Breast Cancer Cell |
pmid |
sentence |
20530684 |
The cyclin e/cdk2 complex phosphorylates cdc25c on ser(214), leading to its premature activation, which coincides with higher cyclin b/cdk1 and polo-like kinase 1 (plk1) activities in an s-phase-enriched population that result in faster mitotic entry. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CyclinE/CDK2 | down-regulates
phosphorylation
|
TFCP2 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216713 |
Ser309 |
SLGEGNGsPNHQPEP |
Homo sapiens |
|
pmid |
sentence |
19237534 |
In vitro, lsf is phosphorylated by cyclin e/cyclin-dependent kinase 2 (cdk2), cyclin c/cdk2, and cyclin c/cdk3, predominantly on s309. Phosphorylation by cyclin c/cyclin-dependent kinase 2 following mitogenic stimulation of murine fibroblasts inhibits transcriptional activity of lsf during g1 progression |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CyclinE/CDK2 | down-regulates
phosphorylation
|
SIRT2 |
0.404 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216725 |
Ser368 |
PNPSTSAsPKKSPPP |
Homo sapiens |
Neuron |
pmid |
sentence |
18332217 |
We define ser-331 as the site phosphorylated by cyclin e-cdk2, cyclin a-cdk2, and p35-cdk5 both in vitro and in cells. Importantly, phosphorylation at ser-331 inhibits the catalytic activity of sirt2. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CyclinE/CDK2 | up-regulates
phosphorylation
|
UBTF |
0.379 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216678 |
Ser389 |
INKKQATsPASKKPA |
Homo sapiens |
|
pmid |
sentence |
11698641 |
Phosphorylation of ubf at serine 388 is required for interaction with rna polymerase i and activation of rdna transcription. After g(1) progression ubf is phosphorylated at serine 388 by cdk2/cyclin e and cdk2/cyclin a. Conversion of serine 388 to glycine abolishes ubf activity |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CyclinE/CDK2 | up-regulates
phosphorylation
|
RRN3 |
0.485 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216682 |
Ser44 |
LENDFFNsPPRKTVR |
Homo sapiens |
|
pmid |
sentence |
15004009 |
Cdk2/cyclin e-mediated phosphorylation at ser 44 activates tif-ia |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CyclinE/CDK2 | up-regulates activity
phosphorylation
|
UBTF |
0.379 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-250755 |
Ser484 |
ERGKLPEsPKRAEEI |
Mus musculus |
NIH-3T3 Cell |
pmid |
sentence |
10202152 |
We have identified Ser484 as a direct target for cyclin-dependent kinase 4 (cdk4)-cyclin D1- and cdk2-cyclin E-directed phosphorylation. Mutation of Ser484 impairs rDNA transcription in vivo and in vitro. |
|
Publications: |
1 |
Organism: |
Mus Musculus |
+ |
CyclinE/CDK2 | down-regulates
phosphorylation
|
ID2 |
0.445 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216698 |
Ser5 |
sPVRSVRK |
Homo sapiens |
|
pmid |
sentence |
9029153 |
Id2 acts by forming heterodimers that are unable to bind to specific (e-box) dna sequences. Here we show that this activity can be overcome by phosphorylation of a serine residue within a consensus target site for cyclin-dependent kinases (cdks). In vitro, id2 can be phosphorylated by either cyclin e-cdk2 or cyclin a-cdk2_ |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CyclinE/CDK2 | down-regulates activity
phosphorylation
|
RB1 |
0.74 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-250747 |
Ser608 |
TAADMYLsPVRSPKK |
|
C-33A Cell |
pmid |
sentence |
10207050 |
In the present assay, ΔP3,4HA repressed E2F-mediated transcription similarly to wild-type pRB, suggesting that phosphorylation at other sites on ΔP3,4HA can disrupt its interaction with E2F and that these two sites are not sufficient to regulate E2F binding on DNA. This result is consistent with another report which showed that mutation of the human sites 8 and 9 (human Ser608 and Ser612) repressed E2F-mediated transcription to the same level as wild-type pRB (2). | Surprisingly, no one CDK site regulated the interaction of pRB with E2F when E2F was bound to DNA. Instead, disruption of transcriptional repression resulted from accumulation of phosphate groups on the RB molecule. |
|
Publications: |
1 |
Pathways: | FLT3-ITD signaling, Cell cycle: G1/S phase transition, Cell cycle: G2/M phase transition, IGF and Myogenesis, p53 in cancer |
+ |
CyclinE/CDK2 | up-regulates activity
phosphorylation
|
USP37 |
0.459 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-265053 |
Ser628 |
MVNSCITsPSTPSKK |
Homo sapiens |
HEK-293 Cell, HeLa Cell |
pmid |
sentence |
21596315 |
There is positive reinforcement of this signaling mechanism because phosphorylation of Ser628 by CDK2/cyclin E and CDK2/cyclin A complexes produces maximal USP37 activity |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CyclinE/CDK2 | up-regulates
phosphorylation
|
PRKAR1A |
0.306 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216729 |
Ser83 |
DSREDEIsPPPPNPV |
Homo sapiens |
MCF-7 Cell |
pmid |
sentence |
16582606 |
In this context, we have identified rialpha as a novel substrate for the g(1)/s-cyclin-dependent kinase, cdk2/cyclin e, and found that rialpha is specifically phosphorylated at the serine residue. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CyclinE/CDK2 | up-regulates activity
phosphorylation
|
PARP10 |
0.305 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-273594 |
Thr101 |
QGLPPGTtPQRLEQH |
in vitro |
|
pmid |
sentence |
16455663 |
The PARP activity of PARP10 depends on phosphorylation by CDK2-cyclin E in vitro. CDK-phosphorylated PARP10 is absent in growth-arrested cells. These results suggest that PARP10 functions in cell proliferation and may serve as a marker for proliferating cells.our results suggest that nucleolar PARP10 acquires CDK2-cyclin E-dependent phosphorylation at the Thr-101 residue. |
|
Publications: |
1 |
Organism: |
In Vitro |
+ |
CyclinE/CDK2 | down-regulates activity
phosphorylation
|
NPM1 |
0.415 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-250744 |
Thr199 |
VKKSIRDtPAKNAQK |
|
|
pmid |
sentence |
11278991 |
Here, we identified that threonine 199 (Thr(199)) of NPM/B23 is the major phosphorylation target site of CDK2-cyclin E in vitro, and the same site is phosphorylated in vivo.|NPM/B23 binds specifically to unduplicated centrosomes and loses its centrosome binding activity when phosphorylated by CDK2-cyclin E |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216662 |
Thr234 |
SFKKQEKtPKTPKGP |
Homo sapiens |
|
pmid |
sentence |
12058066 |
Both subtypes of B23 proteins were phosphorylated during mitosis by cyclin B/cdc2. The RNA binding activity of B23.1 was repressed through cyclin B/cdc2-mediated phosphorylation at specific sites in B23. Thus, the RNA binding activity of B23.1 is stringently modulated by its phosphorylation and subtype association. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216690 |
Thr234 |
SFKKQEKtPKTPKGP |
Homo sapiens |
|
pmid |
sentence |
14670079 |
We have recently found that nucleophosmin (npm/b23), a phosphoprotein primarily found in nucleolus, associates with unduplicated centrosomes and is a direct substrate of cdk2-cyclin e in centrosome duplication. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216674 |
Thr234 |
SFKKQEKtPKTPKGP |
Homo sapiens |
|
pmid |
sentence |
11278991 |
We have recently found that nucleophosmin (npm/b23), a phosphoprotein primarily found in nucleolus, associates with unduplicated centrosomes and is a direct substrate of cdk2-cyclin e in centrosome duplication. |
|
Publications: |
4 |
Organism: |
, Homo Sapiens |
+ |
CyclinE/CDK2 | up-regulates
phosphorylation
|
SF3B1 |
0.354 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216686 |
Thr244 |
GRAKGSEtPGATPGS |
Homo sapiens |
|
pmid |
sentence |
12105215 |
To map the set of phosphorylation sites in sap155-(223-322) that determine its interaction with nipp1, we have identified phosphorylation sites of cyclin e-cdk2 by the sequencing of proteolytically derived phosphopeptide). Three phosphorylation sites were identified as thr244, thr248, and thr313 |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216666 |
Thr248 |
GSETPGAtPGSKIWD |
Homo sapiens |
|
pmid |
sentence |
12105215 |
To map the set of phosphorylation sites in sap155-(223-322) that determine its interaction with nipp1, we have identified phosphorylation sites of cyclin e-cdk2 by the sequencing of proteolytically derived phosphopeptides. Three phosphorylation sites were identified as thr244, thr248, and thr313 |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
+ |
CyclinE/CDK2 | up-regulates activity
phosphorylation
|
E2F5 |
0.627 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-262732 |
Thr261 |
SQSLTPVtPQKSSMA |
Homo sapiens |
|
pmid |
sentence |
10783242 |
Here we show that E2F-5 is phosphorylated by the cyclin E-Cdk2 complex, which functions in the late G1 phase, but not by the early-G1-phase-acting cyclin D-CDK complex. A phosphorylation site in the trans-activation domain of E2F-5 stimulates transcription and cell-cycle progression by the recruitment of the p300/CBP family of co-activators, whose binding to E2F-5 is stabilized upon phosphorylation by cyclin E-Cdk2. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CyclinE/CDK2 |
phosphorylation
|
SF3B1 |
0.354 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216717 |
Thr313 |
HGSGWAEtPRTDRGG |
Homo sapiens |
|
pmid |
sentence |
12105215 |
We indeed found that sap155-(223_322) and sap155-(1_491) are excellent substrates for in vitrophosphorylation by cyclin e-cdk2 as well as cyclin b-cdk1 |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CyclinE/CDK2 | up-regulates activity
phosphorylation
|
CDC7 |
0.585 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-250726 |
Thr376 |
QVAPRAGtPGFRAPE |
|
|
pmid |
sentence |
10846177 |
Among four possible Cdk phosphorylation sites of huCdc7, replacement of Thr-376, corresponding to the activating threonine of Cdk, with alanine (T376A mutant) dramatically reduces kinase activity, indicative of kinase activation by phosphorylation of this residue. In vitro, Cdk2-Cyclin E, Cdk2-Cyclin A, and Cdc2-Cyclin B, but not Cdk4-Cyclin D1, phosphorylates the Thr-376 residue of huCdc7, suggesting possible regulation of huCdc7 by Cdks. |
|
Publications: |
1 |
+ |
CyclinE/CDK2 |
phosphorylation
|
PRC1 |
0.351 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-250745 |
Thr470 |
LYGSAPRtPSKRRGL |
|
|
pmid |
sentence |
9885575 |
We have shown that PRC1 is a good in vitro substrate for several CDKs, and that it is also phosphorylated in a cell cycle–dependent manner in vivo at Thr-481 (major mitosis. and Thr-470 (minor site), which are the in vitro phosphorylation sites. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-250746 |
Thr481 |
RRGLAPNtPGKARKL |
|
|
pmid |
sentence |
9885575 |
We have shown that PRC1 is a good in vitro substrate for several CDKs, and that it is also phosphorylated in a cell cycle–dependent manner in vivo at Thr-481 (major mitosis. and Thr-470 (minor site), which are the in vitro phosphorylation sites. |
|
Publications: |
2 |
+ |
CyclinE/CDK2 | up-regulates
phosphorylation
|
HIRA |
0.331 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216670 |
Thr555 |
LSPSVLTtPSKIEPM |
Homo sapiens |
|
pmid |
sentence |
11238922 |
Hira bound to and was phosphorylated by cyclin a- and e-cdk2 in vitrohira became phosphorylated on threonine 555 in s phase when cyclin-cdk2 kinases are active.ectopic expression of hira in cells caused arrest in s phase and this is consistent with the notion that it is a cyclin-cdk2 substrate that has a role in control of the cell cycle. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CyclinE/CDK2 | up-regulates
phosphorylation
|
MCM3 |
0.62 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216694 |
Thr722 |
EEMPQVHtPKTADSQ |
Homo sapiens |
|
pmid |
sentence |
21965652 |
In this study, we demonstrate that mcm3 is a substrate of cyclin e/cdk2 and can be phosphorylated by cyclin e/cdk2 at thr-722. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CyclinE/CDK2 | down-regulates
phosphorylation
|
TP73 |
0.515 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216702 |
Thr86 |
AASASPYtPEHAASV |
Homo sapiens |
|
pmid |
sentence |
12676926 |
Cyclin-dependent kinases phosphorylate p73 at threonine 86 in a cell cycle-dependent manner and negatively regulate p73.Furthermore, cyclin a/cdk1/2, cyclin b/cdk1/2, and cyclin e/cdk2 complexes can phosphorylate multiple p73 isoforms in vitro at threonine 86. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
MAPK1 | up-regulates
phosphorylation
|
CyclinE/CDK2 |
0.387 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-217499 |
|
|
Homo sapiens |
|
pmid |
sentence |
12359725 |
In addition to its role in stimulating cyclin d1 expression and nuclear translocation of cdk2, erk regulates thr-160 phosphorylation of cdk2-cyclin e. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CDKN1B | down-regulates activity
binding
|
CyclinE/CDK2 |
0.878 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-217505 |
|
|
Homo sapiens |
|
pmid |
sentence |
17409098 |
P27, an important cell cycle regulator, blocks the g(1)/s transition in cells by binding and inhibiting cdk2/cyclin a and cdk2/cyclin e complexes (cdk2/e). |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Cell cycle: G1/S phase transition, Cell cycle: G2/M phase transition, Integrin Signaling |
+ |
CyclinE/CDK2 | up-regulates
|
G1/S_transition |
0.7 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-245480 |
|
|
Homo sapiens |
|
pmid |
sentence |
21524151 |
In its hypophosphorylated state, pRb binds transcription factors of the E2F family which are required for cell cycle progression. As the level of CyclinD/Cdk4/6 complexes increases, pRb becomes phosphorylated and progression through G1 occurs. At a critical level of phosphorylation, E2F is released from pRb. This activates the transcription of CyclinE which complexes with Cdk2 to fully release pRb repression by further phosphorylation, establishing a positive feedback loop. E2F further promotes the transcription of S-phase genes. Thus, CyclinD/Cdk4/6 and CyclinE/Cdk2 together regulate S-phase entry via phosphorylating pRb, which controls pRb binding to E2F |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Cell cycle: G1/S phase transition, Cell cycle: G2/M phase transition, Integrin Signaling, p53 in cancer |
+ |
E2F1 | up-regulates quantity by expression
transcriptional regulation
|
CyclinE/CDK2 |
0.569 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-245471 |
|
|
Homo sapiens |
|
pmid |
sentence |
8649818 |
We have found that cell cycle regulation of cyclin E transcription is mediated by E2F binding sites present in the promoter. The activity of this promoter can be regulated negatively by pRB. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Cell cycle: G1/S phase transition, Cell cycle: G2/M phase transition |
+ |
CDC25A | up-regulates activity
dephosphorylation
|
CyclinE/CDK2 |
0.737 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-245452 |
|
|
Homo sapiens |
MCF-7 Cell |
pmid |
sentence |
11154267 |
Cyclin E-Cdk2 complexes from p16INK4a-expressing MCF-7 cells are activated in vitro and in vivo by Cdc25A |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Cell cycle: G1/S phase transition, Cell cycle: G2/M phase transition |
+ |
TGFB1 | down-regulates activity
|
CyclinE/CDK2 |
0.279 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-217502 |
|
|
Homo sapiens |
|
pmid |
sentence |
10611320 |
Tgf-beta treatment resulted in the specific inactivation of cyclin cdk2 complexes caused by absence of the activating thr(160) phosphorylation on cdk2. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Cell cycle: G1/S phase transition |
+ |
CyclinE/CDK2 | up-regulates
|
Proliferation |
0.7 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-262532 |
|
|
Homo sapiens |
|
pmid |
sentence |
21524151 |
In its hypophosphorylated state, pRb binds transcription factors of the E2F family which are required for cell cycle progression. As the level of CyclinD/Cdk4/6 complexes increases, pRb becomes phosphorylated and progression through G1 occurs. At a critical level of phosphorylation, E2F is released from pRb. This activates the transcription of CyclinE which complexes with Cdk2 to fully release pRb repression by further phosphorylation, establishing a positive feedback loop. E2F further promotes the transcription of S-phase genes. Thus, CyclinD/Cdk4/6 and CyclinE/Cdk2 together regulate S-phase entry via phosphorylating pRb, which controls pRb binding to E2F |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | FLT3-ITD signaling, Integrin Signaling |
+ |
CDKN1A | down-regulates activity
binding
|
CyclinE/CDK2 |
0.887 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-245462 |
|
|
Homo sapiens |
MCF-7 Cell |
pmid |
sentence |
11154267 |
Overexpression of p16INK4a in cells with functional pRb results in inhibition of both Cdk4- and Cdk6-associated kinase activity and pRb phosphorylation, with subsequent cell cycle arrest (46, 50). In addition, inhibition of D cyclin-Cdk4 complex formation by p16INK4a prevents sequestration of p21Cip1 and p27Kip1 by these complexes in early G1, leading to suppression of cyclin E-Cdk2 activity |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | FLT3-ITD signaling, Cell cycle: G1/S phase transition, Cell cycle: G2/M phase transition, p53 in cancer |
+ |
CDK2 | form complex
binding
|
CyclinE/CDK2 |
0.931 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-187457 |
|
|
Homo sapiens |
|
pmid |
sentence |
19665013 |
The eukaryotic cell cycle is controlled by different cyclins and their associated kinases (murray and hunt, 1993). In mammalian cells, levels of cycline and its associated kinase, cdk2, rise in late g1/early s-phase when dna replication is initiated |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CCNE2 | form complex
binding
|
CyclinE/CDK2 |
0.931 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-187454 |
|
|
Homo sapiens |
|
pmid |
sentence |
19665013 |
The eukaryotic cell cycle is controlled by different cyclins and their associated kinases (murray and hunt, 1993). In mammalian cells, levels of cycline and its associated kinase, cdk2, rise in late g1/early s-phase when dna replication is initiated |
|
Publications: |
1 |
Organism: |
Homo Sapiens |